Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine-ketamine versus ketamine-midazolam sedation for pediatric TOF cardiac CT
PACTR201906664920036Phase 0Completed
- Sponsor
- Hoda shokri
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0, open-label trial of dexmedetomidine, ketamine and midazolam in tetralogy of Fallot (TOF) (2 arms), sponsored by Hoda shokri. Primary endpoint: Recovery time. Started Mar 2019; status: completed.
02
Drugs
dexmedetomidineketaminemidazolam
03
Conditions
tetralogy of Fallot (TOF)
Beyond the preview
Go deeper on PACTR201906664920036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201906664920036.